Zydus Cadila, one of the two largest manufacturers of key Covid drug hydroxychloroquine (HCQ), has ramped up its production by nearly 10X to 30 metric tonnes (15 crore tablets of 200mg) per month in view of the huge spike in demand expected due to rising cases of Covid-19.from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/2V9CDqu
